Refractory Chronic Cough Improvement Via NAL ER (RIVER)

NCT05962151 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

66

Enrollment

INDUSTRY

Sponsor class

Conditions

Refractory Chronic Cough

Interventions

DRUG: NAL ER
DRUG: Placebo

Sponsor

Trevi Therapeutics